Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA392036
Max Phase: Preclinical
Molecular Formula: C13H12Cl2F3N3
Molecular Weight: 338.16
Molecule Type: Small molecule
Associated Items:
ID: ALA392036
Max Phase: Preclinical
Molecular Formula: C13H12Cl2F3N3
Molecular Weight: 338.16
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCc1nnn(-c2c(Cl)cc(C(F)(F)F)cc2Cl)c1CC
Standard InChI: InChI=1S/C13H12Cl2F3N3/c1-3-10-11(4-2)21(20-19-10)12-8(14)5-7(6-9(12)15)13(16,17)18/h5-6H,3-4H2,1-2H3
Standard InChI Key: UNBQMUNNSLPLLQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 338.16 | Molecular Weight (Monoisotopic): 337.0360 | AlogP: 4.72 | #Rotatable Bonds: 3 |
Polar Surface Area: 30.71 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 0.54 | CX LogP: 5.32 | CX LogD: 5.32 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.81 | Np Likeness Score: -1.61 |
1. Alam MS, Huang J, Ozoe F, Matsumura F, Ozoe Y.. (2007) Synthesis, 3D-QSAR, and docking studies of 1-phenyl-1H-1,2,3-triazoles as selective antagonists for beta3 over alpha1beta2gamma2 GABA receptors., 15 (15): [PMID:17544280] [10.1016/j.bmc.2007.05.039] |
Source(1):